Humanigen Inc reports results for the quarter ended in March - Earnings Summary

Humanigen

18/05/2023 03:04

* Humanigen Inc  HGEN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 6 cents per
share.
    * Revenue fell 78.7% to $221.00 thousand from a year ago;
analysts
expected zero. 
    * Humanigen Inc's reported EPS for the quarter was a loss
of 4
cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Humanigen Inc shares had risen by 4.2% this quarter and
gained 24.6% so far this year.
    * The company reported a quarterly loss of $4.18 million.
    * Wall Street's median 12-month price target for Humanigen
Inc is
$0.33 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
18 at 02:04 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.06          -0.04          Beat
 Dec. 31 2022      -0.06          0.05           Beat
 Sep. 30 2022      -0.18          -0.23          Missed
 Jun. 30 2022      -0.30          -0.43          Missed